AngioDynamics to Present at the Needham Virtual Healthcare Conference

Rhea-AI Summary

AngioDynamics, Inc. (NASDAQ: ANGO) has announced that President and CEO Jim Clemmer, along with Executive VP and CFO Stephen Trowbridge, will present at the Needham 22nd Annual Virtual Healthcare Conference on April 17, 2023, at 8:00 a.m. ET. The presentation aims to showcase the company’s innovative medical technologies focused on enhancing blood flow and cancer treatment options, ultimately improving patient quality of life.

A live webcast will be available in the “Investors” section of AngioDynamics’ website, with a replay accessible post-event. The presentation highlights the company’s commitment to addressing unmet patient needs through its transformative medical solutions.

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the Needham 22^nd Annual Virtual Healthcare Conference at 8:00 a.m. ET on Monday, April 17, 2023.

A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following the event.

About AngioDynamics, Inc.

AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients.

The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230411005783/en/

Investor Contact:

AngioDynamics, Inc.

Stephen Trowbridge, Executive Vice President & CFO

(518) 795-1408

Source: AngioDynamics, Inc.

FAQ

When is AngioDynamics' presentation at the Needham 22nd Annual Virtual Healthcare Conference?

AngioDynamics will present at the Needham 22nd Annual Virtual Healthcare Conference on April 17, 2023, at 8:00 a.m. ET.

Who will represent AngioDynamics at the Needham Conference?

Jim Clemmer, President and CEO, and Stephen Trowbridge, Executive VP and CFO, will represent AngioDynamics at the conference.

How can I watch the AngioDynamics presentation online?

You can watch the AngioDynamics presentation live through the “Investors” section of their website at www.angiodynamics.com.

What is the focus of AngioDynamics as a medical technology company?

AngioDynamics focuses on restoring healthy blood flow, expanding cancer treatment options, and improving the quality of life for patients.